Key Takeaways
- Renae Walker contracted measles at five months old, before she was eligible for vaccination, and initially recovered uneventfully.
- A decade later she developed subacute sclerosing panencephalitis (SSPE), a rare but fatal neurological complication of measles that can surface years after infection.
- SSPE presented with seizures, behavioral changes, hallucinations, and progressive neurological decline, ultimately leading to life‑support withdrawal and her death in September 2023.
- Measles remains a serious threat: about 20 % of infected children require hospitalization, 5 % develop pneumonia (the leading cause of death), and 10 % suffer ear infections that can cause permanent hearing loss.
- Vaccination rates for measles and other routine immunisations have been falling in the UK, the United States, and Australia since the COVID‑19 pandemic, eroding hard‑won elimination status.
- Public‑health experts warn that vaccine hesitancy, misinformation, and reduced access to services are driving the resurgence, underscoring the need for renewed trust‑building and improved vaccine access.
The onset of Renae’s illness
When Rebecca Archer’s five‑month‑old daughter Renae developed a fever, turned pale and struggled to breathe, Rebecca called an ambulance. The infants were rushed to hospital, where clinicians diagnosed measles. After a brief inpatient stay, Renae was discharged with a drip and the family isolated for a week. She appeared to recover fully, and the episode seemed like a routine childhood illness at the time.
Diagnosis and early recovery
The measles infection was confirmed in early 2013 during a local outbreak near Manchester, England. Because routine measles‑mumps‑rubella (MMR) vaccination is not administered until the first birthday, Renae was too young to have received the vaccine. Despite the severity of her initial symptoms, she responded well to supportive care and was sent home after a short hospitalisation.
Years of apparent health
For the next ten years, Renae grew into a “kind” and “bubbly” child who excelled at school and brought laughter to those around her. Rebecca recalled her daughter as her best friend, noting that there were no obvious lingering effects from the measles bout. The virus, however, had not been cleared from her body; it remained latent, silently replicating in her brain.
First neurological warning signs
In July 2023, just before Renae’s eleventh birthday, Rebecca received a call from the school reporting that Renae had suffered a seizure. Physicians initially attributed the event to epilepsy and referred her to a neurology specialist. Over the following days, Renae complained of headaches, became sensitive to noise, and experienced a second seizure, signalling that something more serious was underway.
Escalation of symptoms and medical confusion
Renae’s condition deteriorated rapidly. She began snapping at siblings, required assistance with basic hygiene, and started hallucinating. Over two months she cycled in and out of hospital, yet clinicians could not pinpoint a cause. She grew progressively weaker, struggled to keep her eyes open, and eventually stopped eating. A week in intensive care followed, during which she was intubated and lost the ability to speak.
Diagnosis of SSPE and final days
An MRI revealed worsening swelling in Renae’s brain, but the underlying etiology remained elusive until days before her death. A lumbar puncture and blood tests finally detected measles virus particles in her cerebrospinal fluid, leading to a diagnosis of subacute sclerosing panencephalitis (SSPE). SSPE is a rare, progressive, and invariably fatal complication of measles that typically manifests seven to ten years after the initial infection. Heavily pregnant with her third child, Rebecca faced the agonising decision to withdraw life support; she underwent a C‑section the next day and returned to Renae’s bedside as her daughter slipped away.
Understanding SSPE as a measles complication
SSPE occurs when the measles virus persists in the central nervous system, triggering chronic inflammation and neuronal loss. Early symptoms are subtle—behavioural changes, mild cognitive decline, or occasional seizures—but they evolve into severe motor dysfunction, blindness, and coma. There is no curative treatment; management is limited to palliative care. Renae’s trajectory exemplifies how a seemingly benign childhood measles infection can culminate in a tragic, delayed neurological demise.
Broader measles complications in children
Beyond SSPE, measles poses immediate dangers. Approximately one in five infected children requires hospitalisation, one in twenty develops pneumonia—the leading cause of measles‑related death—and one in ten suffers an ear infection that can result in permanent hearing loss. These complications underscore why timely vaccination is critical, especially for infants who are too young to be immunised and rely on herd immunity for protection.
Current measles resurgence in the UK
The United Kingdom is experiencing a renewed measles outbreak, with vaccination rates declining each year since the COVID‑19 pandemic. The World Health Organization has stripped Britain of its measles‑elimination status, indicating that the virus is now circulating locally. Public‑health officials warn that even small drops in uptake can trigger outbreaks because measles is extraordinarily contagious.
Expert insight from Vanessa Saliba on vaccine hesitancy
Vanessa Saliba, a consultant epidemiologist at the UK Health Security Agency, describes measles as the “canary in the coal mine” for immunisation programmes. She notes a year‑on‑year decline in coverage across all childhood vaccines, driven by complex factors including reduced access to health services, limited vaccine information, and eroding trust in medical advice. Restoring confidence and improving access will require sustained community engagement and targeted outreach.
Measles trends in the United States and Australia
The United States faced its worst measles outbreak in decades last year, resulting in the deaths of two unvaccinated schoolgirls. In Australia, Professor Margie Danchin of the Royal Children’s Hospital reports the lowest measles vaccination coverage for children in a decade, with declining rates for the past five‑to‑six years. Immunisation registers reveal under‑vaccinated pockets in northern New South Wales, the Gold Coast, parts of Western Australia, and suburbs of Melbourne and Sydney.
Rebecca’s advocacy and concluding message
Rebecca Archer continues to honour Renae’s memory by urging other parents to recognise the real dangers of vaccine‑preventable diseases. She expresses anger and sorrow that families still underestimate the risk of foregoing immunisation, emphasizing that a simple jab could have prevented her daughter’s tragic fate. Her story serves as a stark reminder that vaccines, though victims of their own success, remain essential safeguards against diseases that can resurface with devastating consequences when protection wanes.